STAT

Vertex says its drug successfully reduced marker of kidney disease in late-stage trial

Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a key marker of a kidney ...
BioSpace

Vertex’s Nephropathy Asset Delivers ‘Strong’ Late-Stage Data, Clears Path to FDA

Vertex Pharmaceuticals has a rolling biologics license application with the FDA for povetaciceptin IgA nephropathy. With new data from RAINIER, the biotech expects to complete its submission by the ...

Vertex Rises as Kidney Drug Meets Goal in Late-Stage Trial

Vertex Pharmaceuticals Inc. shares rose after the biotech company said its drug to treat a kidney disorder met its goal in a late-stage trial, providing a boost to its strategy of moving beyond cystic ...
eWeek

Gemini Beats Claude, GPT in Google’s First Android AI Coding Benchmark

Google’s new Android Bench ranks the top AI models for Android coding, with Gemini 3.1 Pro Preview leading Claude Opus 4.6 and GPT-5.2-Codex.